Veryan Medical Limited

Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London, based on the pioneering work by Professor Colin Caro (Emeritus Professor of Physiological Mechanics, Dept. of Bioengineering Imperial College) on the link between vessel geometry, blood flow mechanics and vascular disease. Veryan used its understanding of swirling flow and its expertise in research and development to design, develop and patent the highly innovative three-dimensional (3D), nitinol (nickel-titanium alloy) BioMimics 3D Vascular Stent System. With our long track record of R&D, clinical, regulatory and commercial achievements and the support and endorsement of notable, international KOLs, we bring real, practical, unique solutions to challenges that physicians face daily; delivering intelligent design and improved clinical outcomes. Veryan became an Otsuka Medical Devices company in 2018. Otsuka Medical Devices is a member of the Otsuka group, a total healthcare company. The Otsuka group advances businesses in a variety of fields – ranging from pharmaceuticals to beverages and foods – to contribute to the health of people around the world. Read more about the Otsuka group. At Veryan, we look for entrepreneurial people who are ready to make a difference. Veryan has an industry leading Executive team with deep sector expertise, a proven track record and over 200 years’ experience in Healthcare.